Style | Citing Format |
---|---|
MLA | Abdollahi H, et al.. "The Biochemical Parameters and Vitamin D Levels in Icu Patients With Covid-19: A Cross-Sectional Study." Endocrine# Metabolic and Immune Disorders - Drug Targets, vol. 21, no. 12, 2021, pp. 2191-2202. |
APA | Abdollahi H, Salehinia F, Badeli M, Karimi E, Gandomkar H, Asadollahi A, Sedighiyan M, Abdolahi M (2021). The Biochemical Parameters and Vitamin D Levels in Icu Patients With Covid-19: A Cross-Sectional Study. Endocrine# Metabolic and Immune Disorders - Drug Targets, 21(12), 2191-2202. |
Chicago | Abdollahi H, Salehinia F, Badeli M, Karimi E, Gandomkar H, Asadollahi A, Sedighiyan M, Abdolahi M. "The Biochemical Parameters and Vitamin D Levels in Icu Patients With Covid-19: A Cross-Sectional Study." Endocrine# Metabolic and Immune Disorders - Drug Targets 21, no. 12 (2021): 2191-2202. |
Harvard | Abdollahi H et al. (2021) 'The Biochemical Parameters and Vitamin D Levels in Icu Patients With Covid-19: A Cross-Sectional Study', Endocrine# Metabolic and Immune Disorders - Drug Targets, 21(12), pp. 2191-2202. |
Vancouver | Abdollahi H, Salehinia F, Badeli M, Karimi E, Gandomkar H, Asadollahi A, et al.. The Biochemical Parameters and Vitamin D Levels in Icu Patients With Covid-19: A Cross-Sectional Study. Endocrine# Metabolic and Immune Disorders - Drug Targets. 2021;21(12):2191-2202. |
BibTex | @article{ author = {Abdollahi H and Salehinia F and Badeli M and Karimi E and Gandomkar H and Asadollahi A and Sedighiyan M and Abdolahi M}, title = {The Biochemical Parameters and Vitamin D Levels in Icu Patients With Covid-19: A Cross-Sectional Study}, journal = {Endocrine# Metabolic and Immune Disorders - Drug Targets}, volume = {21}, number = {12}, pages = {2191-2202}, year = {2021} } |
RIS | TY - JOUR AU - Abdollahi H AU - Salehinia F AU - Badeli M AU - Karimi E AU - Gandomkar H AU - Asadollahi A AU - Sedighiyan M AU - Abdolahi M TI - The Biochemical Parameters and Vitamin D Levels in Icu Patients With Covid-19: A Cross-Sectional Study JO - Endocrine# Metabolic and Immune Disorders - Drug Targets VL - 21 IS - 12 SP - 2191 EP - 2202 PY - 2021 ER - |